CROI 2014: Advances in antiretroviral therapy

Topics in Antiviral Medicine

Volumn 22, Issue 2, 2014, Pages 616-631

  Taylor, Barbara S ^a   Shalev, Noga ^b   Wilkin, Timothy J ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cascade of care; CROI 2014; Cure; HIV; Resource limited; Treatment

Indexed keywords

ANTIRETROVIRUS AGENT;

CHEMOPROPHYLAXIS; DISEASE TRANSMISSION; HEALTH; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN; PREVENTION AND CONTROL; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHEMOPREVENTION; DISEASE TRANSMISSION, INFECTIOUS; GLOBAL HEALTH; HIV INFECTIONS; HUMANS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84906883507     PISSN: 21615861     EISSN: 21615853     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Persaud D, Gay H, Ziemniak C, et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med. 2013;369(19):1828-1835.
2. Bendavid E, Holmes CB, Bhattacharya J, Miller G. HIV development assistance and adult mortality in Africa. JAMA. 2012;307(19):2060-2067.
3. Chasela CS, Hudgens MG, Jamieson DJ, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med. 2010;362(24):2271-2281.